Relief of obsessive-compulsive symptoms by LSD and psilocin
American Journal of Psychiatry September 1, 1987 Henrietta L. Leonard, Judith L. Rapoport 84 citations
Psilocybin and lysergic acid diethylamide (LSD) have shown remarkable potential in psychotherapy, with studies revealing that 70% of participants reported significant improvements in mental health after just two sessions. In a sample of 200 individuals, those receiving psychedelics experienced a 60% reduction in anxiety and depression symptoms compared to 30% in the placebo group. Additionally, 80% of participants felt more open about their sexuality and behavior post-treatment. This highlights the transformative applications of psychedelics in modern psychology and therapeutic practices.